Leukocyte and lymphocyte cyclic AMP responses in atopic eczema
- PMID: 192803
- DOI: 10.1111/1523-1747.ep12494569
Leukocyte and lymphocyte cyclic AMP responses in atopic eczema
Abstract
Lymphocytes from subjects with mild and severe atopic eczema were compared with normal control subjects in regard to their cAMP (3';5'-cyclic adenosine monophosphate) responses to a variety of stimulatory agents. Individuals in the severe eczema group were shown to have a significant diminution in their unstimulated lymphocyte cAMP levels and absolute cAMP responses to 0.5 mM theophylline, 0.5 mM theophyline + 1 micronM epinephrine, 10 mM isoproternol, 1 mM isoproterenol, 10 mM salbutamol, and 3 micron M PGE1. Individuals with mild eczema had a reduced response to 0.5 mM theophylline. The severe eczema groups also differed in a number of these responses from a group of 5 subjects with severe psoriasis. Mixed leukocyte cAMP responses to 10 mM isoproterenol also were examined and found to be diminished in individuals with eczema.
Similar articles
-
Decreased adrenergic responses in lymphocytes and granulocytes in atopic eczema.J Allergy Clin Immunol. 1976 Nov;58(5):586-96. doi: 10.1016/0091-6749(76)90205-0. J Allergy Clin Immunol. 1976. PMID: 185243
-
Impaired lymphocyte cyclic adenosine monophosphate responses in atopic eczema.Br J Dermatol. 1983 Nov;109(5):559-64. doi: 10.1111/j.1365-2133.1983.tb07679.x. Br J Dermatol. 1983. PMID: 6315045
-
Alterations in cyclic AMP metabolism in human bronchial asthma. II. Leukocyte and lymphocyte responses to prostaglandins.J Clin Invest. 1973 Jun;52(6):1336-41. doi: 10.1172/JCI107305. J Clin Invest. 1973. PMID: 4349946 Free PMC article.
-
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents.J Clin Invest. 1973 Jan;52(1):48-59. doi: 10.1172/JCI107173. J Clin Invest. 1973. PMID: 4404909 Free PMC article.
-
Impaired monocyte cyclic AMP responses and monocyte cytotoxicity in atopic dermatitis.Allergy. 1980 Dec;35(8):647-55. doi: 10.1111/j.1398-9995.1980.tb02017.x. Allergy. 1980. PMID: 6261605
Cited by
-
Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease.Drugs. 2003;63(23):2575-94. doi: 10.2165/00003495-200363230-00002. Drugs. 2003. PMID: 14636078 Review.
-
Inhibition of IgE-mediated histamine release from human leukocytes by a new xanthine derivative, D 4026.Agents Actions. 1980 Nov;10(5):403-10. doi: 10.1007/BF01968037. Agents Actions. 1980. PMID: 6163338
-
Pharmacophysiology of atopic dermatitis.Clin Rev Allergy. 1986 Feb;4(1):43-65. doi: 10.1007/BF02991187. Clin Rev Allergy. 1986. PMID: 3008974 Review.
-
Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.J Allergy Clin Immunol Pract. 2020 Jan;8(1):91-101. doi: 10.1016/j.jaip.2019.06.044. Epub 2019 Aug 29. J Allergy Clin Immunol Pract. 2020. PMID: 31474543 Free PMC article. Review.
-
Impaired monocyte-mediated cytotoxicity in atopic dermatitis.Arch Dermatol Res. 1980;269(1):21-9. doi: 10.1007/BF00404454. Arch Dermatol Res. 1980. PMID: 7447489
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources